Nascent Biotech Inc

Company Profile

Nascent Biotech Inc had its IPO on under the ticker symbol NBIO.

The company operates in the Healthcare sector and Biotechnology industry. Nascent Biotech Inc has a staff strength of 0 employees.

Stock update

Shares of Nascent Biotech Inc opened at $0.08 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.08 - $0.09, and closed at $0.08.

This is a +6.41% increase from the previous day's closing price.

A total volume of 433,750 shares were traded at the close of the day’s session.

In the last one week, shares of Nascent Biotech Inc have increased by +47.69%.

Nascent Biotech Inc's Key Ratios

Nascent Biotech Inc has a market cap of $11.67 million, indicating a price to book ratio of 6.9097 and a price to sales ratio of 21.7794.

In the last 12-months Nascent Biotech Inc’s revenue was $0 with a gross profit of $1 million and an EBITDA of $0. The EBITDA ratio measures Nascent Biotech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nascent Biotech Inc’s operating margin was 0% while its return on assets stood at -976.21% with a return of equity of 0%.

In Q2, Nascent Biotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Nascent Biotech Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nascent Biotech Inc’s profitability.

Nascent Biotech Inc stock is trading at a EV to sales ratio of 21.8279 and a EV to EBITDA ratio of -48.353. Its price to sales ratio in the trailing 12-months stood at 21.7794.

Nascent Biotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$78922.00

Total Liabilities

$1.23 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Nascent Biotech Inc ended 2024 with $78922.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $78922.00 while shareholder equity stood at $-1155034.00.

Nascent Biotech Inc ended 2024 with $0 in deferred long-term liabilities, $1.23 million in other current liabilities, in common stock, $-22162999.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9480.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Nascent Biotech Inc’s total current assets stands at $78922.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Nascent Biotech Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Nascent Biotech Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.08

52-Week High

$0.4515

52-Week Low

$0.0323

Analyst Target Price

$

Nascent Biotech Inc stock is currently trading at $0.08 per share. It touched a 52-week high of $0.4515 and a 52-week low of $0.4515. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.07 and 200-day moving average was $0.09 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 4164.2% of the company’s stock are held by insiders while 74.6% are held by institutions.